Can-Fite BioPharma Ltd. (CANF) is a clinical-stage biotechnology company developing small molecule therapeutics for cancer, inflammatory diseases, and other conditions. Its core business activities are Shariah-compliant, focusing on health-promoting R&D. However, high interest income from cash reserves (30.12% of revenue) results in financial non-compliance across standards. The company is not included in major Shariah indices due to this impurity. Purification of 30.12% of dividends is required, and investors should monitor for improvements in financial management.